• SPX
  • $5,712.69
  • -0.28 %
  • -$16.11
  • DJI
  • $41,794.60
  • -0.61 %
  • -$257.59
  • N225
  • $38,474.90
  • 1.11 %
  • $421.23
  • FTSE
  • $8,207.67
  • 0.29 %
  • $23.43
  • IXIC
  • $18,179.98
  • -0.33 %
  • -$59.93
Regeneron Pharmaceuticals, Inc. (REGN) Earning

Regeneron Pharmaceuticals, Inc. (REGN) Earning

NASDAQ Currency in USD Disclaimer

Stock Price

$828.16

-$15.44

(-1.83%)

Day's range
$826.76
Day's range
$852

Regeneron Pharmaceuticals, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 3 $10.17 $10.17 $10.17
Q2 2024 6 $10.62 $10.62 $10.62
Q3 2024 7 $11.61 $11.77 $11.69
Q4 2024 16 $9.01 $12.83 $11.00
Q1 2025 4 $9.71 $12.15 $10.94
Q2 2025 2 $11.50 $13.29 $12.39
Q3 2025 2 $11.98 $13.84 $12.91
Q4 2025 2 $10.89 $12.58 $11.73

Regeneron Pharmaceuticals, Inc. Earnings Date And Information

Regeneron Pharmaceuticals, Inc. last posted its earnings results on Thursday, October 31st, 2024. The company reported $12.46 earnings per share for the quarter, topping analysts' consensus estimates of $11.69 by $0.77. The company had revenue of 3.72 B for the quarter and had revenue of 13.12 B for the year. Regeneron Pharmaceuticals, Inc. has generated $37 earnings per share over the last year ($34.77 diluted earnings per share) and currently has a price-to-earnings ratio of 19.25. Regeneron Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based on prior year's report dates.

Regeneron Pharmaceuticals, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
10/31/2024 Q3 2024 $11.69 $12.40 0.71 $3.67 B $3.72 B
08/01/2024 Q2 2024 $10.61 $13.25 2.64 $3.38 B $3.55 B
05/02/2024 Q1 2024 $10.17 $6.70 -3.47 $3.15 B
02/05/2024 Q4 2023 $10.88 $3.43 B
11/02/2023 Q3 2023 $10.72 $9.48 -1.24 $3.23 B $3.36 B
08/03/2023 Q2 2023 $9.84 $9.05 -0.79 $3.02 B $3.16 B
05/04/2023 Q1 2023 $9.25 $7.64 -1.61 $3.16 B
02/06/2023 Q4 2022 $11.19 $3.41 B
11/03/2022 Q3 2022 $9.48 $11.66 2.18 $2.92 B $2.94 B
08/03/2022 Q2 2022 $8.53 $7.47 -1.06 $2.79 B $2.86 B
05/04/2022 Q1 2022 $9.74 $8.61 -1.13 $2.97 B
02/07/2022 Q4 2021 $20.99 $4.95 B
11/04/2021 Q3 2021 $10.10 $15.37 5.27 $2.75 B $3.45 B
08/05/2021 Q2 2021 $17.53 $29.51 11.98 $3.96 B $5.14 B
05/06/2021 Q1 2021 $9.00 $10.58 1.58 $2.53 B
02/08/2021 Q4 2020 $10.90 $2.42 B
11/05/2020 Q3 2020 $7.14 $7.98 0.84 $2.08 B $2.29 B
08/05/2020 Q2 2020 $5.98 $8.19 2.21 $1.73 B $1.95 B
05/05/2020 Q1 2020 $6.13 $5.69 -0.44 $1.83 B
02/07/2020 Q4 2019 $7.25 $2.17 B
 

Regeneron Pharmaceuticals, Inc. Earnings: Frequently Asked Questions

  • When is Regeneron Pharmaceuticals, Inc.'s earnings date?

    Regeneron Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based off last year's report dates.

  • Did Regeneron Pharmaceuticals, Inc. beat their earnings estimates last quarter?

    In the previous quarter, Regeneron Pharmaceuticals, Inc. (:REGN) reported $12.46 earnings per share (EPS) to beat the analysts' consensus estimate of $11.69 by $0.77.

  • How can I listen to Regeneron Pharmaceuticals, Inc.'s earnings conference call?

    The conference call for Regeneron Pharmaceuticals, Inc.'s latest earnings report can be listened to online.

  • How can I read Regeneron Pharmaceuticals, Inc.'s conference call transcript?

    The conference call transcript for Regeneron Pharmaceuticals, Inc.'s latest earnings report can be read online.

  • How much revenue does Regeneron Pharmaceuticals, Inc. generate each year?

    Regeneron Pharmaceuticals, Inc. (:REGN) has a recorded annual revenue of $13.12 B.

  • How much profit does Regeneron Pharmaceuticals, Inc. generate each year?

    Regeneron Pharmaceuticals, Inc. (:REGN) has a recorded net income of $13.12 B. Regeneron Pharmaceuticals, Inc. has generated $37.05 earnings per share over the last four quarters.

  • What is Regeneron Pharmaceuticals, Inc.'s price-to-earnings ratio?

    Regeneron Pharmaceuticals, Inc. (:REGN) has a price-to-earnings ratio of 19.25 and price/earnings-to-growth ratio is 2.66.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.